III° IANA (International Academy on Nutrition and Aging) on
- Nutrition, Exercise & Alzheimer's Disease
- Clinical Trials on Sarcopenia
August 1st and 2nd , 2008
Tamaya Hyatt Regency – Albuquerque, NM, USA
Organized by the University of New Mexico,
School of Medicine
Clinical Nutrition Program, Aging Process Study
CMEWeb@salud.unm.edu; www.healthandage.com/html/min/iananda; abq.iana@gmail.com

Workshop Chairs: Phil Garry (Albuquerque); Bruno Vellas (Toulouse); Nancy Emerson Lombardo (Boston); Wm Cameron Chumlea (Dayton); Martha C Morris (Chicago); J.E. Morley (Saint-Louis)

Target Audience: Scientists from all fields, physicians, nurses, public health educators and administrators, dietitians, service providers, and students.

Late Breaking News: Abstract must be submitted between June 1 and June 30, 2008

Friday, August 1st , 2008

7.30 am: Registration

8.00 am to 8.30: Introduction: B. Vellas (France), P. Garry (USA)

8.30 am to 10.00 am: Symposium I: Physical Exercise and Cognitive Functions
- Physical exercise and cognitive decline in animal models. Carl W. Cotman (Irvine)
- Physical activity and cognitive function in humans. Patricia C. Heyn (Colorado)
- Effect of fish oil supplementation on cognitive performance in older subjects: A randomized, double-blind, placebo controlled trial. Ondine van de Rest (The Netherlands)
- Physical activity and enhanced fitness improve cognitive function in older people without known cognitive impairment, a Cochrane systematic Review. M. Angevaren, G. Aufdemkampe, H.J.J. Verhaar, A. Aleman, L. Vanhees (The Netherlands)

10.00 am to 10.30 am: Refreshment Break and Poster Session

10.30 am to 12.00 pm: Symposium II: Nutrition and Cognitive Decline
- The role of nutrients in Alzheimer's disease: the rationale and methodology for a systematic review... Peter J. Whitehouse (Cleveland)
- Beyond magic bullets: An evidence-based nutrition program for persons with Alzheimer's and MCI. Nancy Emerson Lombardo (Boston)
- Health promotion program and nutrition in Alzheimer's disease: The NutriActive study. Antoni Salva (Barcelona, Spain)
- Metabolism disorders, vascular risk factors and cognitive decline in hispanic elderly. L. Jaime Fitten (Los Angeles)

12 pm to 1.00 pm:  Lunch and Poster Session

1.00 pm to 3.00 pm: Symposium III: Sarcopenia- How to define it?
Co-chairs: Tamara B. Harris, MD, NIA, U.S. & Zhao Chen, PhD, MPH, University of Arizona, U.S. Panel Members: Marjolein Visser, PhD, University of Amsterdam, the Netherlands; Lynn M. Marshall, ScD, Oregon Health and Science University, U.S.; Scott B. Going , PhD, University of Arizona, U.S.
- Symposium overview. Tamara B. Harris (Bethesda)
- Status and challenges for sarcopenia definition. Scott B. Going (Tucson)
- NHANES data on sarcopenia. Tamara B. Harris (Bethesda)
- Sarcopenia in the U.S. older men - results from Mr. OS Cohort Study. Lynn M. Marshall (Portland)
- Sarcopenia in the U.S. older women - an analysis with the WHI cohort. Zhao Chen (Tucson)
- Sarcopenia in the European population. Marjolein Visser (Amsterdam, the Netherlands)
- A comparison of the health ABC results with other cohorts, Tamara B. Harris (Bethesda)
- How to define sarcopenia? Panel discussion with meeting participants
- Conclusion. Zhao Chen (Tucson)

3.00 pm to 4.00 pm: Symposium IV: Frailty, Sarcopenia and Cognitive Decline
- Epidemiology of sarcopenia. Wm Cameron Chumlea (Dayton)
- Frailty and cognitive functions: Denis A. Evans (Chicago)
- Physical activity and Alzheimer's disease in a population study. N. Scarmeas, Y. Stern, N. Schupf, J.A. Luchsinger (USA)

4.00 pm to 4.20 pm: Refreshment Break and Poster Session

4.20 pm to 6.20 pm: Roundtable on Methodological Issues for Clinical Trials in Sarcopenia
- Introduction. B.Vellas (Toulouse, France)
- Clinical trials for sarcopenia: Review and recommendations.W.J. Evans, L. Ferruci (Bethesda)
- Clinicaly relevant outcomes for sarcopenia trials. Roger A. Fielding (Boston)
- How to assess sarcopenia in clinical trials. Stephanie A. Studenski (Pittsburgh)
- Therapeutic potential targets for sarcopenia clinical trials. John E. Morley (St-Louis)
- Target population for clinical trials. Marco Pahor (Florida)
- Testosterone and growth hormone improve body composition and muscle performance in older men: The HORMA trial, F.R. Sattler, C. Castaneda-Sceppa, E.F. Binder, E.T. Schroeder, Y. Wang, S. Bhasin, M. Kawakubo, Y. Stewart, C.S. Hahn, P. Colletti, R. Roubenoff, K.E. Yarasheski, S.P. Azen (USA)

Saturday, August 2, 2008

8.00 am to 9.30 am: IANA Task Force Presentations
- The Task Force on preventive trials in Alzheimer. Sandrine Andrieu (Toulouse, France)
- The Task Force on frailty. G. Abellan Van Kan, Y. Rolland (Toulouse, France)
- The Task Force on nutrition and cognitive decline. Martha C. Morris (Chicago)
- IANA Task Force on memory health clinics. Bruno Vellas (Toulouse, France)

9.30 am to 10.30 am: Nutrition, Aging, Cognition, Muscle
- The metabolic syndrome is a risk factor for vascular dementia, not for Alzheimer's disease, in french elderly persons. The Three-City study. P. Barberger-Gateau (Bordeaux, France)
- Physical exercice and BPSD. P. Robert (Nice, France)
- Under-Eating in hospitalized older adults: Patterns and predictors, outcomes, and opportunities for intervention. J.L. Locher (Birmingham).
- Physical exercise and dementia clinical trials. Eric B. Larson (Seattle)
- Low levels of plasma phosphatidylcholine docosahexaenoic acid are associated with risk of all-cause dementia and Alzheimer's disease: The Rancho Bernardo Study. L.A. Weiss, J. Bergstrom, D. kritz-Silverstein, E. Barrett-Connor (USA)
- Role of DHA in cognitive aging and Alzheimer's disease. K. Yurko-Mauro, E. Nelson, J. Quinn (USA)
- Intramuscular fat in older adults and the impact of resistance training. R.L. Marcus, J. Kidde, L. Dibble, O. Addison, P.C. LaStayo (USA)

10.30 am to 11.00 am: Refreshment Break and Poster Session

11.00 am to 1.00 pm: Nutrition, Exercise, Cognition and Aging
- Dangers of Weight loss in the elderly. Robert R.Wolf (Little Rock)
- Olive Oil and cognition: results from the three-city Study. C. Berr (Montpellier, France)
- Consequences of poor nutrition on indicators of sarcopenia and physical function: A longitudinal prospective, Benedetta Bartali (New Haven)
- High-fat feeding and age impact voluntary wheel running and cognitive function in rat. N. Tümer, M. Judge, T.C. Foster, B. Erdos, I. Cudykier, P.J. Scarpace (USA)
- Let's give people with Alzheimer's (AD) what the Beagles Got... Here's how ! S. Arkin (USA)
- Frailty grip is associated with glucose intolerance: Results from the epidemiological diabetes reduction assessment with ramipril and rosiglitazone medication study population. H. Florez, H. Gerstein, P. Sheridan, J. Bosch, R. Goldberg (USA, Canada)
- The value of high protein oral supplements during rehabilitation of geriatric hip fracture is related to reduced complications and potential cost savings. K.M. Kaspar, S.M. Drawert (USA)

1.00 pm: Conference Adjourns